[PDF][PDF] Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis

NC Chavez-Tapia, I Mendiola-Pastrana… - Annals of …, 2015 - medigraphic.com
Acute-on-chronic liver failure (ACLF) is associated with increased short and long-term
mortality. Animal models of liver failure have demonstrated that granulocyte-colony …

The current status of granulocyte-colony stimulating factor to treat acute-on-chronic liver failure

C Engelmann, V Di Martino, AJC Kerbert… - Seminars in Liver …, 2021 - thieme-connect.com
Patients with acute-on-chronic liver failure (ACLF) have a devastating prognosis and
therapeutic options are limited. Granulocyte-colony stimulating factor (G-CSF) mobilizes …

The platelet receptor CLEC-2 blocks neutrophil mediated hepatic recovery in acetaminophen induced acute liver failure

A Chauhan, L Sheriff, MT Hussain, GJ Webb… - Nature …, 2020 - nature.com
Acetaminophen (APAP) is the main cause of acute liver failure in the West. Specific
efficacious therapies for acute liver failure (ALF) are limited and time-dependent. The …

Xanthohumol, a main prenylated chalcone from hops, reduces liver damage and modulates oxidative reaction and apoptosis in hepatitis C virus infected Tupaia …

M Yang, N Li, F Li, Q Zhu, X Liu, Q Han, Y Wang… - International …, 2013 - Elsevier
Hepatitis C virus (HCV) infection in Tupaia belangeri (Tupaia) represents an important
model of HCV infection. Xanthohumol (XN), a major prenylated chalcone from hops, has …

Emerging and current management of acute‐on‐chronic liver failure

MF Butt, R Jalan - Alimentary Pharmacology & Therapeutics, 2023 - Wiley Online Library
Background Acute‐on‐chronic liver failure (ACLF) is a clinically and pathophysiologically
distinct condition from acutely decompensated cirrhosis and is characterised by systemic …

Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (su PAR) in acute liver failure

A Koch, HW Zimmermann, N Gassler… - Liver …, 2014 - Wiley Online Library
Abstract Background & Aims Acute liver failure (ALF) is a life‐threatening condition with a
high mortality rate. The expression of urokinase plasminogen activator receptor (uPAR …

Efficacy of Granulocyte Colony-Stimulating Factor in Acute on Chronic Liver Failure: A Systematic Review and Survival Meta-Analysis

G Konstantis, G Tsaousi, C Pourzitaki… - Journal of Clinical …, 2023 - mdpi.com
Background: Acute-on-chronic liver failure (ACLF) mostly occurs when there is an acute
insult to the liver in patients with pre-existing liver disease, and it is characterized by a high …

[HTML][HTML] Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety

JP Rodriguez, MP Murphy, S Hong, M Madrigal… - International archives of …, 2012 - Springer
Advancements in rheumatoid arthritis (RA) treatment protocols and introduction of targeted
biological therapies have markedly improved patient outcomes, despite this, up to 50% of …

急性肝衰竭动物模型的研究进展.

龙富立, 林镛, 彭子明, 冯逢, 张建玲… - Journal of Clinical …, 2021 - search.ebscohost.com
急性肝衰竭是一种严重而复杂的肝脏疾病, 短期病死率高, 其发病机制尚未明确,
亦缺乏特效药物. 动物模型制备对于深层次揭露急性肝衰竭发病和药物疗效机制具有重要意义 …

[HTML][HTML] Granulocyte colony stimulating factor treatment in non-alcoholic fatty liver disease: beyond marrow cell mobilization

HH Nam, DW Jun, K Jang, WK Saeed, JS Lee… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Protective effects of granulocyte colony stimulating factor (G-CSF) in acute liver injury via
marrow cell mobilization have been reported in several studies. But exact mode of action …